Tag: Schizophrenia
Polygenic Risk Score Predicts Tx Response in Schizophrenia
PRS significantly predictive of adjusted 12-week symptom scores across four cohorts
Remission of Schizophrenia Seen With Amisulpride, Clozapine
Symptomatic remission achieved for most with sequential administration of amisulpride, clozapine
Substance Use Disorders Linked to Conversion to Schizophrenia
Cannabis, amphetamine, opioid use disorders all linked to conversion from schizotypal disorder
Early Intervention Service Cuts Suicide Rate in Schizophrenia
Early intervention service tied to drop in long-term suicide rate for first-episode schizophrenia disorder
Risk of Breast CA May Be Higher in Women With Schizophrenia
Findings based on a meta-analysis that showed significant study heterogeneity
AVATAR Therapy Promising for Auditory Hallucinations
Reduction in PSYRATS-AH total score significantly greater with AVATAR tx versus supportive counseling
Inflammatory Biomarkers May Impact Risk of Schizophrenia
Protective effect noted for C-reactive protein; risk-increasing effect for soluble interleukin-6 receptor
Specific Efforts May Aid Quality of Life for Schizophrenia Caregivers
Supportive interventions would cut affiliate stigma, enhance family-centered care
Targeted rTMS Effective for Auditory Verbal Hallucinations
Higher percentage of responders among patients in active transcranial magnetic stimulation group
Relapse Down With Clozapine, Injectables in Schizophrenia
Risk of rehospitalization substantially lower with long-acting injectables versus oral equivalents
